Medicare Establishes Final Local Coverage Determination (LCD) for Use of the Oncotype DX Genomic Prostate Score(TM) Test in Patients with Favorable Intermediate-risk Prostate Cancer Effective October 9, 2017
In: PR Newswire, 2017-08-24
Zeitungsartikel
Zugriff:
Titel: |
Medicare Establishes Final Local Coverage Determination (LCD) for Use of the Oncotype DX Genomic Prostate Score(TM) Test in Patients with Favorable Intermediate-risk Prostate Cancer Effective October 9, 2017
|
---|---|
Zeitschrift: | PR Newswire, 2017-08-24 |
Veröffentlichung: | 2017 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|